Medical News

RSS

AABM Team wins two medals in a national contest

The Aquatic Animal Bio-Medicine R&D Team (AABM Team) of National Cheng Kung University (NCKU) in Taiwan, led by Distinguished Prof. Huey-Lang Yang from Institute of Biotechnology, won two medals out of more than 100 teams in the national contest, “2009 Crazy Idea – King of Practical Applications on Creative Researches and Development of Biotechnology,” organized by the Industrial Development Bureau of the Ministry of Economic Affairs, Taiwan.

25 Sep 2009

Schumer's amendment to the health bill will benefit people with disabilities: United Spinal Association

United Spinal Association praised New York Senator Charles Schumer for introducing an amendment to the Senate Finance Committee health care reform bill to enact the Community Choice Act benefiting people with disabilities.

25 Sep 2009

Susan G. Komen Race for the Cure to raise public awareness about breast cancer

A sea of pink t-shirts will stretch from Athens to Bologna to Frankfurt to Zurich to Antwerp today in an effort to raise public awareness about breast cancer. In five cities across Europe, breast cancer survivors, their families, friends, supporters and advocates will join forces in a show of strength, courage and solidarity.

25 Sep 2009

BSD Medical Corporation announces the filing of shelf registration statement with SEC

BSD Medical Corporation today announced the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission.

25 Sep 2009

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

YM BioSciences Inc. a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational and financial results for its fiscal year end, ended June 30, 2009.

25 Sep 2009

ethica Clinical Research, Matrix Pharma sign worldwide agreement

ethica Clinical Research Inc. ("ethica"), a Contract Research Organization (CRO) headquartered in Montreal, and Matrix Pharma Canada Inc. ("Matrix Pharma"), have announced the signing of an agreement, valued at CAD1.25 Million, that provides ethica with an exclusive, worldwide license to promote and use Matrix Pharma's proprietary research data analysis technology for life sciences applications, notably for the identification and optimization of biomarkers.

25 Sep 2009

Free online guide for health care organizations to improve patient care

Lilly USA and the National Committee for Quality Assurance have collaborated to release a free online guide and resource library for health care organizations that wish to undertake quality improvement initiatives to improve culturally and linguistically appropriate services and reduce disparities in care.

25 Sep 2009

Link between flicking colours and epileptic fits discovered

Researchers have discovered that epileptic brains are more ordered than non-epileptic ones and also that certain flicking colours seem more likely to cause fits.

25 Sep 2009

The Siebel Foundation to fund fellowships for Jacob School's top bioengineering graduate students

As breakthrough discoveries in bioengineering become more crucial to fundamental global issues, including health, food production and water supplies, UC San Diego's Jacobs School of Engineering's top ranked bioengineering department continues to be on the cutting edge of this field. The Siebel Foundation has recognized the Jacob School's pioneering efforts with a $2 million endowment to fund fellowships for some of its top bioengineering graduate students.

25 Sep 2009

Three-day meeting to discuss breakthroughs in prostate cancer

Nearly of 300 of the world’s leading researchers focused on the problem of prostate cancer will begin a three-day meeting today to discuss the latest scientific data and breakthroughs in prostate cancer. The meeting, held in Incline Village at Lake Tahoe in Nevada, is the 16th Scientific Retreat sponsored by the Prostate Cancer Foundation (PCF).

25 Sep 2009

10th Annual Clinical Team Conference to focus on clinical care

More than 1,400 hospice and palliative care professionals and researchers have gathered in Denver for the National Hospice and Palliative Care Organization's 10th Annual Clinical Team Conference that begins today at the Hyatt Regency Denver.

25 Sep 2009

G20 countries could tax foreign exchange to help achieve U.N. MDGs, opinion piece says

The G20 countries "could help both the poor and the global economy by fully financing lagging efforts to fight poverty and disease worldwide, and the best way to do this would be to impose a very small tax on the prosperous foreign exchange industry," Philippe Douste-Blazy, a former French foreign minister who is a special adviser to the U.N. secretary general on innovative financing, writes in a New York Times opinion piece.

25 Sep 2009

Entertainment Arts Research to acquire Explain My Surgery

Entertainment Arts Research, Inc. (EARI) today announced that they have issued a letter of intent to acquire Explain My Surgery, Inc. (EMS) and have the company become a wholly-owned subsidiary of EARI.

25 Sep 2009

Wound Management Technologies inks marketing agreement with Pharma Technology International

Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today an agreement with Pharma Technology International, LLC (Pharma Tech) to market, distribute and sell the company's wound care products in the Middle East. Pharma Tech is a joint venture between A&Z Pharmaceutical and BioPharma Management Technologies, Inc., a company recently acquired by Wound Management Technologies.

25 Sep 2009

First Edition: September 25, 2009

Today's headlines reflect the continuing action in the Senate Finance Committee and around Congress, focusing on legislative strife related to the White House deal with drug companies and the debate over the public plan.

25 Sep 2009

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs. 10.65%,>

25 Sep 2009

Vertex Pharmaceuticals to present SVR data at the 60th Annual Meeting of the American Association

Vertex Pharmaceuticals Incorporated today announced that sustained virologic response (SVR) data from Study C208, which evaluated twice-daily dosing of Vertex’s investigational hepatitis C virus (HCV) protease inhibitor telaprevir, will be presented in an oral presidential plenary session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) taking place Oct. 30 – Nov. 3, 2009 in Boston.

25 Sep 2009

UHP's electronic health record system recognized

Urban Health Plan in the South Bronx is revolutionizing the way patients are identified and tracked at their network of community health centers. From identifying patients through an iris recognition scan to managing their patients' health through a fully electronic system, UHP is able to provide state-of-the-art, quality and comprehensive care to thousands of New York's neediest residents. This week, their efforts were recognized by the Healthcare Information and Management Systems Society who awarded them the 2009 HIMSS Davies Award of Excellence. Urban Health Plan uses eClinicalWorks (ECW) as its electronic health record (EHR) system.

25 Sep 2009

Baylor Health Care receives $20 million donation from Sammons Enterprises

Today the Baylor Health Care System Foundation announced gifts exceeding $20 million for what will be North Texas' largest outpatient cancer center and first dedicated hospital focusing on cancer patients.

25 Sep 2009

ACP releases paper promoting increased funding for FDA

A new policy paper that calls for broader authority and increased funding for the Food and Drug Administration (FDA) was released today by the American College of Physicians (ACP). Improving FDA Regulation of Prescription Drugs offers a half-dozen recommendations about how to improve the agency's ability to approve and monitor new drugs.

25 Sep 2009